ZS/DC_S-015

N/A

Report date: 2022/01/06 14:17:59

Base Information

Drug NameZS/DC_S-015
Drug Alias NameZS/DC_S-015
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPancreatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A